AngioDynamics Reports Fiscal 2016 First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Canaccord Genuity Cuts Price Target on AngioDynamics (ANGO) Following 1Q16
October 9, 2015 8:55 AM EDTCanaccord Genuity maintained a Buy rating on AngioDynamics (NASDAQ: ANGO), and cut the price target to $17.50 (from $19.00), following the company's 1Q16 earnings results. ANGOs salesforce has now converted approximately 45% of Morpheus customers over to BioFlow, with BioFlow PICC sales up 22% during the quarter.... More
Piper Jaffray Cuts Price target on AngioDynamics (ANGO) Following 1Q16 Results
October 9, 2015 8:12 AM EDTPiper Jaffray maintained a Neutral rating on AngioDynamics (NASDAQ: ANGO), and cut the price target to $14.00 (from $18.00), following the company's 1Q16 earnings results. Revenues missed, coming in at $83.7M, and earnings were in line with expectations.
Analyst Thomas Gunderson commented, "ANGO essentially... More
AngioDynamics (ANGO) Reports In-Line Q1 EPS, Offers Q2 and FY16 Guidance
October 8, 2015 4:04 PM EDTAngioDynamics (NASDAQ: ANGO) reported Q1 EPS of $0.11, in-line with the analyst estimate of $0.11. Revenue for the quarter came in at $83.7 million versus the consensus estimate of $84.7 million.
AngioDynamics sees Q2 2016 EPS of $0.13-$0.15, versus the consensus of $0.16. AngioDynamics sees Q2 2016 revenue of $87-91 million,... More
